3 completed, 1 active not recruiting, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Active not recruiting 1, Unknown 1 |
Follow Dysentery, Bacillary: new trials by email Literature Review of Dysentery, Bacillary trials Research Report on Dysentery, Bacillary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine S. Flexneri-S. Sonnei bivalent conjugate vaccine, Placebo - Dysentery, Dysentery, Shigella | Phase 3 | Active not recruiting | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 8000 | 2025-05-12 | 2026-04-01 |
| Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine, Placebo - Dysentery, Shigellosis | Phase 3 | Unknown | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 21000 | 2021-12-11 | 2022-01-11 |
| Rifaximin for Prevention of Travellers' Diarrhea Rifaximin, Placebo - Diarrhea | Phase 3 | Completed | Bausch Health Americas, Inc. | 210 | 2005-06-01 | 2019-12-18 |
| Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel Shigella conjugate vaccines - Shigellosis | Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2799 | 2003-01-01 | 2012-06-22 |
| Zinc Supplementation in Shigella Patients Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks. - Testing Effect of Intervention | Phase 3 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 56 | 1999-01-01 | 2006-05-03 |
Dysentery (3) · Diarrhea (1) · Escherichia coli Infections (1)
Bacterial Infections (5) · Bacterial Infections and Mycoses (5) · Digestive System Diseases (5) · Enterobacteriaceae Infections (5) · Gastroenteritis (5) · Gastrointestinal Diseases (5) · Gram-Negative Bacterial Infections (5) · Infections (5) · Intestinal Diseases (5) · Dysentery (2) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Rifaximin (1)
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (2) · Bausch Health Americas, Inc. (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1)
Bangladesh (1) · China (1) · Israel (1) · Mexico (1)
Lin Du (2) · Rachel Schneerson, MD (1) · Swapan Kumar Roy, MBBS, M.Sc, Ph. D (1)